UPDATE: Credit Suisse Downgrades Cubist Pharmaceuticals (CBST) to Neutral
Tweet Send to a Friend
(Updated - November 20, 2014 11:13 AM EST)
Credit Suisse downgraded Cubist Pharmaceuticals (NASDAQ: CBST) from Outperform to Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Credit Suisse downgraded Cubist Pharmaceuticals (NASDAQ: CBST) from Outperform to Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
